CHANGES IN INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE INDIVIDUALS

被引:486
作者
CLERICI, M
HAKIM, FT
VENZON, DJ
BLATT, S
HENDRIX, CW
WYNN, TA
SHEARER, GM
机构
[1] NCI,EXPTL IMMUNOL BRANCH,BLDG 10,ROOM 4B-17,BETHESDA,MD 20892
[2] NIAID,PARASIT DIS LAB,BETHESDA,MD 20892
[3] WILFORD HALL USAF MED CTR,HIV UNIT,LACKLAND AFB,TX 78236
[4] NCI,BIOSTAT & DATA MANAGEMENT SECT,BETHESDA,MD 20892
关键词
INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-10; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; T-LYMPHOCYTES;
D O I
10.1172/JCI116294
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Infection with HIV results in an incremental loss of T helper cell (TH) function, which can occur years before CD4 cell numbers are critically reduced and AIDS is diagnosed. All TH function is not affected, however, because B cell activation and hypergammaglobulinema are also characteristic of this period. Recently, in a murine model of AIDS an early loss in production of the CD4 cytokines IL-2 and IFN-gamma was correlated with an increase in the B cell stimulatory cytokines IL-4, IL-5, and IL-10. We therefore assessed the production of IL-4 generated by PBL from HIV-seropositive (HIV+) individuals who did not have AIDS, yet who exhibited different TH functional categories based on their IL-2 production profiles. We observed that the decreases in recall antigen-stimulated IL-2 production were accompanied by an increase in IL-4 production. The loss of recall antigen-stimulated responses in HIV+ individuals could be reversed in vitro by anti-IL4 antibody. Our results suggest that the TH functions assessed by IL-4 production replace the normally dominant TH function of antigen-stimulated IL-2 production in the progression toward AIDS, and raise the possibility of cytokine cross-regulation in AIDS therapy.
引用
收藏
页码:759 / 765
页数:7
相关论文
共 52 条
[1]   A FACTOR FROM CD8 CELLS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS SUPPRESSES HLA SELF-RESTRICTED T-HELPER CELL RESPONSES [J].
CLERICI, M ;
ROILIDES, E ;
VIA, CS ;
PIZZO, PA ;
SHEARER, GM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (18) :8424-8428
[2]   ACCESSORY CELL-FUNCTION IN ASYMPTOMATIC HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
SHEARER, GM .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1990, 54 (02) :168-173
[3]   EXPOSURE TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SPECIFIC T-HELPER CELL RESPONSES BEFORE DETECTION OF INFECTION BY POLYMERASE CHAIN-REACTION AND SERUM ANTIBODIES [J].
CLERICI, M ;
BERZOFSKY, JA ;
SHEARER, GM ;
TACKET, CO .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (01) :178-182
[4]   CELL-MEDIATED IMMUNE-RESPONSE TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 IN SERONEGATIVE HOMOSEXUAL MEN WITH RECENT SEXUAL EXPOSURE TO HIV-1 [J].
CLERICI, M ;
GIORGI, JV ;
CHOU, CC ;
GUDEMAN, VK ;
ZACK, JA ;
GUPTA, P ;
HO, HN ;
NISHANIAN, PG ;
BERZOFSKY, JA ;
SHEARER, GM .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (06) :1012-1019
[5]   DETECTION OF 3 DISTINCT PATTERNS OF T-HELPER CELL DYSFUNCTION IN ASYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE PATIENTS - INDEPENDENCE OF CD4+ CELL NUMBERS AND CLINICAL STAGING [J].
CLERICI, M ;
STOCKS, NI ;
ZAJAC, RA ;
BOSWELL, RN ;
LUCEY, DR ;
VIA, CS ;
SHEARER, GM .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :1892-1899
[6]   SERUM SUPPRESSION OF LYMPHOCYTE-ACTIVATION INVITRO IN ACQUIRED IMMUNODEFICIENCY DISEASE [J].
CUNNINGHAMRUNDLES, S ;
MICHELIS, MA ;
MASUR, H .
JOURNAL OF CLINICAL IMMUNOLOGY, 1983, 3 (02) :156-165
[7]   PURIFIED PROTEIN DERIVATIVE OF MYCOBACTERIUM-TUBERCULOSIS AND EXCRETORY-SECRETORY ANTIGEN(S) OF TOXOCARA-CANIS EXPAND INVITRO HUMAN T-CELLS WITH STABLE AND OPPOSITE (TYPE-1 T-HELPER OR TYPE-2 T-HELPER) PROFILE OF CYTOKINE PRODUCTION [J].
DELPRETE, GF ;
DECARLI, M ;
MASTROMAURO, C ;
BIAGIOTTI, R ;
MACCHIA, D ;
FALAGIANI, P ;
RICCI, M ;
ROMAGNANI, S .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (01) :346-350
[8]  
DIAMOND DC, 1988, J IMMUNOL, V141, P3715
[9]   DECREASED ACCESSORY CELL-FUNCTION OF MACROPHAGES AFTER INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INVITRO [J].
ENNEN, J ;
SEIPP, I ;
NORLEY, SG ;
KURTH, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (11) :2451-2456
[10]   2 TYPES OF MOUSE T-HELPER CELL .4. TH2 CLONES SECRETE A FACTOR THAT INHIBITS CYTOKINE PRODUCTION BY TH1 CLONES [J].
FIORENTINO, DF ;
BOND, MW ;
MOSMANN, TR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (06) :2081-2095